{{Rsnum
|rsid=8176749
|Gene=ABO
|Chromosome=9
|position=133255801
|Orientation=plus
|ReferenceAllele=G
|GMAF=0.123
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=ABO
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.0 | 15.0 | 85.0
| HCB | 6.6 | 27.7 | 65.7
| JPT | 1.8 | 32.7 | 65.5
| YRI | 3.4 | 26.2 | 70.3
| ASW | 5.3 | 14.0 | 80.7
| CHB | 6.6 | 27.7 | 65.7
| CHD | 1.8 | 25.7 | 72.5
| GIH | 7.9 | 34.7 | 57.4
| LWK | 4.5 | 24.5 | 70.9
| MEX | 0.0 | 15.5 | 84.5
| MKK | 1.9 | 21.4 | 76.6
| TSI | 1.0 | 14.7 | 84.3
| HapMapRevision=28
}}

This SNP is in the [[ABO]] gene, and is therefore potentially useful in determing [[ABO blood group]], such as through the use of [[genosets]].

{{PMID Auto GWAS
  |PMID=23300138
  |Trait=Tumor biomarkers
  |Title=A genome wide association study of genetic loci that influence tumour biomarkers cancer antigen 19-9, carcinoembryonic antigen and α fetoprotein and their associations with cancer risk.
  |RiskAllele=T
  |Pval=7E-105
  |OR=.21
  |ORtxt=[0.18-0.23] ng/ml increase
  }}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}